Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 72.73%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of $0.09 per share when it actually produced a loss of $0.17, delivering a surprise of -88.89%.Over the last four q ...